Impact of simultaneous assay, the PCNA, cyclinD1, and DNA content with specimens before and after preoperative radiotherapy on prognosis of esophageal cancer-possible incorporation into clinical TNM staging system.

AIM The aim of the present study is to use immunohistochemical methods to investigate the clinical implications of tumor markers in esophageal squamous cell carcinoma and evaluate their impact on prognosis. METHODS From November 1990 to December 1996, 47 patients were treated with preoperative radiation followed by radical esophagectomy. All patients were confirmed pathologically as suffering from squamous cell carcinoma. Immunohistochemical stain was done for PCNA, cyclinD1 protein expression and DNA content analyzed by image cytometry. Kaplan-Meier method for single prognostic factor and log-rank test was used to test the significant difference. Cox stepwise regression model and prognosis index model were used for survival analysis with multiple prognostic factors. RESULTS Radio-pathological change, T stage and N stage, as the traditional prognostic factors had statistical difference in 3-, 5- and 10-year survival rates. While, tumor cell proliferating marked PCNA, cyclinD1 and DNA content served as independent prognostic factors of esophageal carcinoma. There was definitely an identity between the single and multiple factor analyses. PI was more accurate to evaluate the prognosis of esophageal carcinoma. CONCLUSION It is possible that tumor cell proliferating marked PCNA, cyclinD1 and DNA content would become the endpoints for evaluating the prognosis of esophageal carcinoma.

[1]  T. Tajiri,et al.  Biological behavior of mucoepidermoid carcinoma of the esophagus. , 2003, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[2]  G. Kuang,et al.  Association of cyclin D1 (G870A) polymorphism with susceptibility to esophageal and gastric cardiac carcinoma in a northern Chinese population , 2003, International journal of cancer.

[3]  N. Tsubota,et al.  Prediction of lymph node metastasis by p53, p21(Waf1), and PCNA expression in esophageal cancer patients. , 2003, Journal of experimental & clinical cancer research : CR.

[4]  T. Frebourg,et al.  Prognostic value of TP53 transcriptional activity on p21 and bax in patients with esophageal squamous cell carcinomas treated by definitive chemoradiotherapy. , 2002, International journal of radiation oncology, biology, physics.

[5]  Wei-xing Zhao,et al.  [Association of p53, PCNA expression and trace element content in esophageal mucosa]. , 2002, Ai zheng = Aizheng = Chinese journal of cancer.

[6]  Jun Ma,et al.  Prognostic significance of DNA ploidy and proliferative indices in patients with nasopharyngeal carcinoma. , 2002, Ai zheng = Aizheng = Chinese journal of cancer.

[7]  L. Wang,et al.  Endoscopic screening and determination of p53 and proliferating cell nuclear antigen in esophageal multistage carcinogenesis: a comparative study between high- and low-risk populations in Henan, northern China. , 2002, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[8]  Y. Nishimura,et al.  Impact of neoadjuvant chemotherapy on Ki-67 and PCNA labeling indices for esophageal squamous cell carcinomas. , 2001, International journal of radiation oncology, biology, physics.

[9]  Y. Tabira,et al.  Accelerated growth signals and low tumor-infiltrating lymphocyte levels predict poor outcome in T4 esophageal squamous cell carcinoma. , 2000, The Annals of thoracic surgery.

[10]  Y. Doki,et al.  Clinical application of malignancy potential grading as a prognostic factor of human esophageal cancers. , 2000, Surgery.

[11]  Y. Doki,et al.  Cyclin D1 overexpression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma. , 2000, International journal of oncology.

[12]  N. Muñoz,et al.  Independent and joint effects of tobacco smoking and alcohol drinking on the risk of esophageal cancer in men and women , 1999, International journal of cancer.

[13]  K. Chow,et al.  Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors , 1999, American Journal of Gastroenterology.

[14]  K. Sugimachi,et al.  The prognostic significance of the cytophotometric DNA content and its relationship with the argyrophilic nucleolar organizer regions (AgNOR) and proliferating cell nuclear antigen (PCNA) in oesophageal cancer. , 1995, European Journal of Surgical Oncology.

[15]  T. Hattori,et al.  Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. , 1995, The American journal of pathology.

[16]  M. Endo,et al.  Role of DNA ploidy patterns in esophageal squamous cell carcinoma: An ultraviolet microspectrophotometric study , 1994, Cancer.

[17]  O. Kallioniemi,et al.  Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer. , 1993, The American journal of pathology.

[18]  M. Morita,et al.  Cytophotometric DNA content and argyrophilic nucleolar organiser regions of oesophageal carcinoma. , 1993, British Journal of Cancer.

[19]  R. Warnke,et al.  Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity. , 1992, The American journal of pathology.

[20]  K. Sugimachi,et al.  Dna ploidy is closely linked to tumor invasion, lymph node metastasis, and prognosis in clinical gastric cancer , 1988, Cancer.

[21]  J. Szumiło,et al.  Proliferating nuclear antigen (PCNA) as a prognostic factor of squamous cell carcinoma of the oesophagus. , 2001, Medicina.

[22]  M. Furihata,et al.  Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma. , 1998, British Journal of Cancer.

[23]  K. Sugimachi,et al.  DNA ploidy is closely linked to tumor invasion, lymph node metastasis, and prognosis in clinical gastric cancer. , 1988, Cancer.